AIUM's New Guidelines: Revolutionizing Ultrasound Probe Disinfection with Chlorine Dioxide
In a significant advancement for infection control, the American Institute of Ultrasound in Medicine (AIUM) has updated its guidelines to incorporate chlorine dioxide as a viable option for high-level disinfection (HLD) of ultrasound probes. This guideline update, reported by Parker Laboratories, marks a pivotal moment in the healthcare sector, particularly in ultrasound practices, promising both safety and efficiency in disinfection protocols.
Introducing Chlorine Dioxide into Disinfection Protocols
Chlorine dioxide is a chemical compound that has been recognized for its sterilization capabilities across various healthcare applications. As highlighted in the updated AIUM guidelines, this compound will now be utilized for disinfecting ultrasound probes, thus simplifying the previously complex process involving automated reprocessors. Parker Laboratories markets the chlorine dioxide product under the brand name
Tristel ULT™, which has been the only FDA-cleared chlorine dioxide foam disinfectant available in the United States since its approval in 2008. This innovative solution is already approved for use in over thirty-five countries, showcasing its global acceptance and effectiveness in the medical field.
Streamlining the Disinfection Process
Traditionally, achieving compliance with high-level disinfection standards required stringent adherence to protocols involving automated systems and extensive documentation. Many healthcare facilities grapple with the risks associated with complex cleaning regimens, which could lead to equipment being temporarily removed from service for repairs or chemical replacements. Conversely, with Tristel ULT’s application, healthcare professionals can perform disinfection directly at the point of care using proprietary wipes, significantly enhancing workflow and reducing error rates.
The ease and immediacy of this process allow clinicians to disinfect probes right after use, thus eliminating long wait times and increasing availability of equipment. This aspect of the new guidelines not only ensures that healthcare providers can respond more rapidly to patient needs but also fulfills The Joint Commission’s emphasis on infection prevention practices. As Connie Cutler, president and CEO of Chicago Infection Control Inc., aptly states, "Having a high-level disinfection method at the point of care is a game-changer." The inclusion of chlorine dioxide simplifies disinfection processes, empowers clinicians, and importantly, improves patient safety.
Highlighting the Benefits of Tristel ULT
Adopting Tristel ULT provides healthcare professionals with several remarkable benefits:
1.
Point-of-Care Disinfection: Eliminates the need for transporting probes, thereby reducing both turnaround times and the risks of damage.
2.
Simplified Workflow: Reduces the number of steps involved in disinfection, thus easing the burden on healthcare staff and minimizing machine dependency.
3.
Proven Efficacy: With a mere two-minute kill time, it is effective against a wide array of bloodborne pathogens, including C. difficile, HPV, and M. tuberculosis.
4.
Widespread Compatibility: Safe for use with over 1,100 ultrasound probes and transducers.
5.
Digital Traceability: The Tristel 3T app facilitates easy digital tracking, automatically recording each HLD cycle to aid compliance and accreditation efforts.
Recent Research and Impact
The significance of these benefits was underscored at the 2025 annual meeting of the Association for Vascular Access, where a comparative analysis revealed that the workflow and turnaround times achieved with chlorine dioxide foam outperformed other evaluated methods. In the words of Cutler,
“Consistency is the foundation of infection prevention.” By minimizing complexity in disinfection steps, the adherence to protocols is bolstered, ultimately safeguarding patients and maintaining budgets.
Aligning with Accreditation Priorities
As the healthcare industry increasingly scrutinizes ultrasound probe disinfection practices, the updated AIUM guidelines directly respond to a pressing need within hospitals. The incorporation of chlorine dioxide into standard procedures not only aligns with compliance goals but also streamlines practices, essential for effective accreditation surveys. Neal Buchalter, president of Parker Laboratories, emphasizes the relevance of this update:
“Tristel ULT provides an innovative option that aligns with fast-paced care environments, resource limitations, and the uncompromising safety needs.”
Conclusion
The integration of chlorine dioxide into the disinfection protocols for ultrasound probes is a transformative step depicted by the AIUM’s updated guidelines. By transitioning to this effective disinfection solution, healthcare providers can boost compliance, enhance patient safety, and streamline operational workflows – a holistic upgrade that promises a profound impact on infection prevention practices across the medical landscape. For more information about Parker Laboratories and their offerings, visit their website at
www.parkerlabs.com.